Metis TechBio Co., Ltd. Stock Price

Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States. It develops NanoForge, a suite of synergistic technologies that includes novo lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The company also develops specialized platforms, such as AiTEM, AiLNP and AiRNA that simulate, predict, and interpret nanoscale interactions enabling the design, optimization, and validation of advanced nanomaterials and associated payloads. It offers foundational dry-wet data layer integrated dry-wet lab infrastructure; model layer METiS AI foundational models; and application layer METiSAgentv. It serves pharmaceutical companies, biotechnology companies, and medical research institutions. The company was formerly known as Hangzhou Jitai Pharmaceutical Technology Co., Ltd. Metis TechBio Co., Ltd. was incorporated in 2020 and is headquartered in Beijing, China.